198 related articles for article (PubMed ID: 14507598)
21. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer.
Wittenberg J; Cook LS; Rossing MA; Weiss NS
Epidemiology; 1999 Nov; 10(6):761-3. PubMed ID: 10535792
[TBL] [Abstract][Full Text] [Related]
22. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.
Faber MT; Kjær SK; Dehlendorff C; Chang-Claude J; Andersen KK; Høgdall E; Webb PM; Jordan SJ; ; ; Rossing MA; Doherty JA; Lurie G; Thompson PJ; Carney ME; Goodman MT; Ness RB; Modugno F; Edwards RP; Bunker CH; Goode EL; Fridley BL; Vierkant RA; Larson MC; Schildkraut J; Cramer DW; Terry KL; Vitonis AF; Bandera EV; Olson SH; King M; Chandran U; Kiemeney LA; Massuger LF; van Altena AM; Vermeulen SH; Brinton L; Wentzensen N; Lissowska J; Yang HP; Moysich KB; Odunsi K; Kasza K; Odunsi-Akanji O; Song H; Pharaoh P; Shah M; Whittemore AS; McGuire V; Sieh W; Sutphen R; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Pike MC; Risch HA; Jensen A;
Cancer Causes Control; 2013 May; 24(5):989-1004. PubMed ID: 23456270
[TBL] [Abstract][Full Text] [Related]
23. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC; ;
Eur J Cancer; 2008 Nov; 44(16):2477-84. PubMed ID: 18707869
[TBL] [Abstract][Full Text] [Related]
24. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract][Full Text] [Related]
25. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
26. Epithelial ovarian cancers and endometriosis.
Acién P; Velasco I; Acién M; Capello C; Vela P
Gynecol Obstet Invest; 2015; 79(2):126-35. PubMed ID: 25634648
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for epithelial ovarian cancer by histologic subtype.
Gates MA; Rosner BA; Hecht JL; Tworoger SS
Am J Epidemiol; 2010 Jan; 171(1):45-53. PubMed ID: 19910378
[TBL] [Abstract][Full Text] [Related]
28. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
Machida H; Matsuo K; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kanauchi M; Nagase S; Enomoto T; Mikami M
Gynecol Oncol; 2019 Jun; 153(3):589-596. PubMed ID: 30905436
[TBL] [Abstract][Full Text] [Related]
29. Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.
Jung S; Allen N; Arslan AA; Baglietto L; Barricarte A; Brinton LA; Egleston BL; Falk RT; Fortner RT; Helzlsouer KJ; Gao Y; Idahl A; Kaaks R; Krogh V; Merritt MA; Lundin E; Onland-Moret NC; Rinaldi S; Schock H; Shu XO; Sluss PM; Staats PN; Sacerdote C; Travis RC; Tjønneland A; Trichopoulou A; Tworoger SS; Visvanathan K; Weiderpass E; Zeleniuch-Jacquotte A; Dorgan JF
Int J Cancer; 2018 Jan; 142(2):262-270. PubMed ID: 28921520
[TBL] [Abstract][Full Text] [Related]
30. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
[TBL] [Abstract][Full Text] [Related]
31. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.
Rice MS; Murphy MA; Vitonis AF; Cramer DW; Titus LJ; Tworoger SS; Terry KL
Int J Cancer; 2013 Nov; 133(10):2415-21. PubMed ID: 23650079
[TBL] [Abstract][Full Text] [Related]
32. The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3).
Trabert B; Tworoger SS; O'Brien KM; Townsend MK; Fortner RT; Iversen ES; Hartge P; White E; Amiano P; Arslan AA; Bernstein L; Brinton LA; Buring JE; Dossus L; Fraser GE; Gaudet MM; Giles GG; Gram IT; Harris HR; Bolton JH; Idahl A; Jones ME; Kaaks R; Kirsh VA; Knutsen SF; Kvaskoff M; Lacey JV; Lee IM; Milne RL; Onland-Moret NC; Overvad K; Patel AV; Peters U; Poynter JN; Riboli E; Robien K; Rohan TE; Sandler DP; Schairer C; Schouten LJ; Setiawan VW; Swerdlow AJ; Travis RC; Trichopoulou A; van den Brandt PA; Visvanathan K; Wilkens LR; Wolk A; Zeleniuch-Jacquotte A; Wentzensen N;
Cancer Res; 2020 Mar; 80(5):1210-1218. PubMed ID: 31932455
[TBL] [Abstract][Full Text] [Related]
33. Breastfeeding and risk of epithelial ovarian cancer.
Jordan SJ; Siskind V; C Green A; Whiteman DC; Webb PM
Cancer Causes Control; 2010 Jan; 21(1):109-16. PubMed ID: 19779839
[TBL] [Abstract][Full Text] [Related]
34. The impact of perioperative β blocker use on patient outcomes after primary cytoreductive surgery in high-grade epithelial ovarian carcinoma.
Al-Niaimi A; Dickson EL; Albertin C; Karnowski J; Niemi C; Spencer R; Shahzad MM; Uppal S; Saha S; Rice L; Nally AM
Gynecol Oncol; 2016 Dec; 143(3):521-525. PubMed ID: 27693123
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for ovarian cancers with and without microsatellite instability.
Segev Y; Pal T; Rosen B; McLaughlin JR; Sellers TA; Risch HA; Zhang S; Ping S; Narod SA; Schildkraut J
Int J Gynecol Cancer; 2013 Jul; 23(6):1010-5. PubMed ID: 23748177
[TBL] [Abstract][Full Text] [Related]
36. Incidence of serous tubal intraepithelial carcinoma (STIC) by algorithm classification in serous ovarian tumor associated with PAX8 expression in tubal epithelia: a study of single institution in Japan.
Munakata S; Yamamoto T
Int J Gynecol Pathol; 2015 Jan; 34(1):9-18. PubMed ID: 25473747
[TBL] [Abstract][Full Text] [Related]
37. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
[TBL] [Abstract][Full Text] [Related]
38. Hormone replacement therapy and risk of epithelial ovarian cancer.
Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
[TBL] [Abstract][Full Text] [Related]
39. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
[TBL] [Abstract][Full Text] [Related]
40. Anthropometry and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Ness RB; Allen GO
Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]